Geron reported $636.92M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Amgen USD 538M 33.04B Jun/2025
Bio Techne USD 156.76M 155.19M Jun/2025
Cassava Sciences USD 48.31M 48.26M Jun/2025
Cytokinetics USD 119.6M 119.48M Jun/2025
Exelixis USD 270.13M 269.86M Jul/2025
Genmab DKK 10M 56M Mar/2025
Geron USD 636.92M 636.28M Jun/2025
Gilead Sciences USD 1.24B 3M Jun/2025
Incyte USD 194.12M 193.93M Jun/2025
MacroGenics USD 63.21M 62.58M Jun/2025
Novartis USD 793M 0 Dec/2024